Novartis (NVS) Surges 4.0%_ Is This an Indication of Further Gains_
2025-04-14 06:30
https://finance.yahoo.com/news/novartis-nvs-surges-4-0-063000831.html?.tsrc=rss
Oops, something went wrongTip: Try a valid symbol or a specific company name for relevant resultsOops, something went wrongTrump is wrecking his own economic agendaHigher clothing costs from tariffs are coming soon — but not immediately, experts sayWhy Tesla, GM, and Rivian will be hurt most by China's critical minerals export banTrump says he's 'looking at something' to help car companies with tariffsStocks rally for second straight day, while Apple jumps on tech tariff reprieveThe Nasdaq briefly turned red as stocks' relief rally failed to hold in early afternoon tradingAmericans are braced for the biggest unemployment rate jump since the pandemic, a New York Fed survey foundStocks surge as Apple leads way higher after tech's tariff reprieveTrump's temporary tech tariff respite adds to a growing sense that he has a willingness to listen and bendGoldman CEO Solomon warns of 'markedly different operating environment' as dealmaking slowsCorporate earnings take center stage amid tariff turmoil: What to know this weekTrump has tariffs, taxes, and the debt ceiling on a collision course for this summerTrump denies that there was a tariff “exception” for certain electronics announced Friday. (Bloomberg)Tax day 2025 is coming up. Here’s what to know to file by the deadline.Commentary: Put the P/E ratio in timeout for nowMarket chaos signals 'sell America' trade as Trump tariff whipsaw threatens to upend the US economy's soft landingApple was on brink of crisis before tariff concession from Trump (Bloomberg)Corporate earnings take center stage amid tariff turmoil: What to know this weekThe best (and worst) time of year to buy a houseThe Trump family is going all-in on crypto projects, from Bitcoin mining to stablecoins (Bloomberg)How to invest in gold in 4 stepsChanging jobs can disrupt saving for retirement. Here's how to stay on track.Trump exempts phones, computers, chips from ‘reciprocal’ tariffs (Bloomberg)Meet Walmart heir Steuart Walton, the most powerful board member you’ve never heard ofThe tariff uncertainty isn't getting any better in markets: Chart of the Week'T-shirts could be the new eggs': Why Trump's chaotic tariff whipsaw is still a huge threat to inflationGold notches best week since 2020 amid 'shaken' investor confidence in USThe bond market just had one of its most volatile and unusual weeks in recent memoryStocks capped a wild week with a surge higher, as the S&P 500 posted its biggest weekly gain since 2023Stocks swung into rally mode in afternoon trading, with the major indexes all up over 1%. Bond yields pared bigger gains.The major indexes whipsawed to end a volatile week. Treasury yields surged in signs of more instability in the bond market.Consumer sentiment craters further as inflation expectations soar to highest since 1981Dow, S&P 500, Nasdaq slide as China hits US with tariff hike, bank earnings roll inJPMorgan's Dimon says economy is facing 'considerable turbulence'Tariff uncertainty muddies — and refocuses — earnings seasonChina raises tariffs on US goods to 125% from the 84% planned in response to Trump's latest hikeChina already knows Trump's breaking point in their burgeoning trade war, our columnist writesHow the bond market helped make Trump blink on tariffsThe Dow fell 1,000 points, and the S&P 500 and Nasdaq were crushed as stocks resumed a tariff-fueled sell-offTrump's total tariff on China is actually 145%, the White House said, an amount higher than the 125% previously reportedStocks hit session lows as focus turned to the US-China trade war. The Dow lost over 1,200 points, and the Nasdaq plunged 4.5%.The Dow plummeted 900 points and the Nasdaq plunged over 3% as a tariff-fueled sell-off picked up speed again.Stocks plummet as Wall Street's euphoria from Trump's tariff pause gets a reality checkInflation unexpectedly tumbled in March, and core CPI rose at its slowest pace in four years.The EU matched Trump's 90-day pause on tariffs to 'give negtiations a chance.' See our live updates.The 'Trump put' makes an appearanceMarch's report could be last time investors see inflation easing. Here's what to expect.Stocks wanted one thing from Trump after his shocking tariff announcement last week. They finally got it today.Stocks staged a wild rally after Trump's tariff reversal. The Dow gained near 3,000 points and the S&P 500 had its best day since 2008.Trump nodded to market turbulence as a factor in his 'reciprocal' tariff pause, saying investors were 'yippy' and 'afraid'Unlock stock picks and a broker-level newsfeed that powers Wall Street.NovartisNVS shares ended the last trading session 4% higher at $107.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.2% loss over the past four weeks.This rise in share price came after the Swiss drugmaker announced plans to expand its U.S.-based manufacturing and R&D footprint. Novartis said it would invest $23 billion in 10 facilities, including seven brand new facilities, over the next five years to boost production in the country.This drugmaker is expected to post quarterly earnings of $2.06 per share in its upcoming report, which represents a year-over-year change of +14.4%. Revenues are expected to be $12.86 billion, up 8.7% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Novartis, the consensus EPS estimate for the quarter has been revised 3% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on NVS going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Novartis belongs to the Zacks Large Cap Pharmaceuticals industry. Another stock from the same industry,Johnson & JohnsonJNJ, closed the last trading session 2% higher at $151.73. Over the past month, JNJ has returned -8.8%.Johnson & Johnson's consensus EPS estimate for the upcoming report has changed -0.6% over the past month to $2.57. Compared to the company's year-ago EPS, this represents a change of -5.2%. Johnson & Johnson currently boasts a Zacks Rank of #3 (Hold).Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free reportNovartis AG (NVS) : Free Stock Analysis ReportJohnson & Johnson (JNJ) : Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchThe European Commission approves RHHBY's Columvi combo to treat adult patients with diffuse large B-cell lymphoma after initial therapy.The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.Recursion Pharmaceuticals (RXRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.Johnson & Johnson  is scheduled to report its  fiscal first-quarter earnings before markets open on Tuesday, but the company has bigger hurdles to clear than meeting Wall Street’s expectations.  While shares have lagged behind the  for the past three years, J&J remains up 6.7% in 2025 versus the broader market’s 8.1% decline.  Part of the appeal is J&J’s resilience in the face of a potential recession.ConocoPhillips (COP) closed at $86.45 in the latest trading session, marking a +0.07% move from the prior day.Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.Investors need to pay close attention to U.S. Bancorp (USB) stock based on the movements in the options market lately.A Nasdaq bounce looks to be brewing on Monday after U.S. officials moved to temporarily exempt smartphones, laptops, and other high-end electronics from the Trump administration’s sweeping 145% tariffs on Chinese imports.NEW YORK (Reuters) -U.S. stocks ended higher on Monday, with Apple giving the S&P 500 its biggest boost as the White House exempted smartphones and computers from new tariffs.  Uncertainty over future tariffs kept a lid on optimism, with the main indexes finishing off their highs of the day.  Investors remain worried about how companies will manage supply chains as more changes are expected on the tariff front.Tip: Try a valid symbol or a specific company name for relevant resultsSign in to access your portfolioTry again.